Hyperfine, Inc.
General ticker "HYPR" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $77.0M (TTM average)
Hyperfine, Inc. follows the US Stock Market performance with the rate: 41.0%.
Estimated limits based on current volatility of 4.9%: low 1.16$, high 1.28$
Factors to consider:
- Total employees count: 111 (-15.3%) as of 2024
- Countries other than US accounted for 49.6% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operational and conduct risks, Product quality issues, Consumer perception, Strategic risks and growth management, Trade uncertainties
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.56$, 1.46$]
- 2025-12-31 to 2026-12-31 estimated range: [0.52$, 1.36$]
Financial Metrics affecting the HYPR estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -60.93 <= 0.04
- Positive: Industry inventory ratio change (median), % of -1.22 <= -0.18
- Positive: Shareholder equity ratio, % of 83.26 > 64.17
- Positive: Inventory ratio change, % of -3.80 <= -0.76
- Positive: Investing cash flow per share per price, % of -0.60 > -0.62
- Negative: negative Net income
Short-term HYPR quotes
Long-term HYPR plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $6.81MM | $11.03MM | $12.89MM |
| Operating Expenses | $80.69MM | $59.15MM | $56.11MM |
| Operating Income | $-73.87MM | $-48.12MM | $-43.22MM |
| Non-Operating Income | $0.71MM | $3.88MM | $2.50MM |
| R&D Expense | $28.16MM | $22.49MM | $22.50MM |
| Income(Loss) | $-73.16MM | $-44.24MM | $-40.72MM |
| Profit(Loss)* | $-73.16MM | $-44.24MM | $-40.72MM |
| Stockholders Equity | $123.72MM | $84.40MM | $49.04MM |
| Inventory | $4.62MM | $6.58MM | $5.83MM |
| Assets | $134.05MM | $94.20MM | $58.90MM |
| Operating Cash Flow | $-72.34MM | $-41.81MM | $-38.77MM |
| Capital expenditure | $0.58MM | $0.80MM | $0.38MM |
| Investing Cash Flow | $-0.58MM | $-0.80MM | $-0.38MM |
| Financing Cash Flow | $0.01MM | $0.17MM | $1.02MM |
| Earnings Per Share** | $-1.04 | $-0.62 | $-0.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.